Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Preoperative Anemia and Blood Transfusion Requirement during Hip Surgery: Synthetic and Real Patient Cohort Data

Tsofia Inbar, MD, Eldad J Dann, MD

Blood (2019) 134 (Supplement_1): 3693.

https://doi.org/10.1182/blood-2019-125252

Published: 2019

Journal Articles

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

Teresa Cafaro, MD, Vicky Tagalakis, MD FRCPC, Maral Koolian, MD FRCPC, Simard Camille, MD

Blood (2019) 134 (Supplement_1): 2445.

https://doi.org/10.1182/blood-2019-128849

Published: 2019

Journal Articles

One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B

Steven Pipe, MD, Adam Giermasz, MD PhD, Giancarlo Castaman, MD, Nigel S. Key, MBChB, FRCP, Susan U Lattimore, Frank Leebeek, MD PhD, Wolfgang Miesbach, MD PhD, Michael Recht, MD PhD, Esteban Gomez, MD, Alison Long, Robert Gut, Annette von Drygalski, MD PharmD

Blood (2019) 134 (Supplement_1): 3348.

https://doi.org/10.1182/blood-2019-128765

Published: 2019

Journal Articles

Risk of Venous Thrombosis in Patients with Sickle Cell Trait after Orthopedic Surgery

Jahnavi Gollamudi, MD, Sadeer Al-Kindi, MD, Petra Martin, MD, Jane Little, MD, Lalitha V. Nayak, MD

Blood (2018) 132 (Supplement 1): 417.

https://doi.org/10.1182/blood-2018-99-114353

Published: 2018

Journal Articles

Outcomes of Hip Arthroplasty in Sickle Cell Disease: A 20 Year Retrospective Review

Karina D'Souza, MD, Ayanna Baptiste, MBBS, Jai Jung, MD, Rita Bellevue, MD

Blood (2018) 132 (Supplement 1): 2286.

https://doi.org/10.1182/blood-2018-99-119539

Published: 2018

Journal Articles

Osteonecrosis of the Femoral Head in Sickle Cell Disease: Prevalence, Comorbidities and Surgical Outcomes in California

Oyebimpe O Adesina, MD, Ann M Brunson, MS, Jason R. Gotlib, MD, Theresa Keegan, PhD MS, Ted Wun, MD

Blood (2016) 128 (22): 2489.

https://doi.org/10.1182/blood.V128.22.2489.2489

Published: 2016

Journal Articles

Multiple Myeloma Progression: Dependence on Bone Marrow Adipose Tissue

Michaela Reagan, PhD, Carolyne Falank, PhD, Heather Fairfield, MS, Michelle McDonald, PhD, Peter Croucher, BSc, PhD, Clifford J. Rosen, MD

Blood (2016) 128 (22): 3262.

https://doi.org/10.1182/blood.V128.22.3262.3262

Published: 2016

Journal Articles

Total Hip Replacement in a Hemophilia-a Patient with High Titer Inhibitor

Zühre Kaya, Associate Professor, Özlem Orhan, Sacit Turanli, Profesor, Türkiz Gürsel, Professor, Ulker Kocak, MD, Idil Yenicesu, Professor

Blood (2015) 126 (23): 4707.

https://doi.org/10.1182/blood.V126.23.4707.4707

Published: 2015

Journal Articles

Treatment Outcomes in Pediatric Patients with Pulmonary Embolism Using Low Dose Tissue Plasminogen Activator Therapy

Chittalsinh M Raulji, MD, Mary Silverburg, Justin Farge, MD, Maria Velez, MD, Jaime Morales, MD

Blood (2014) 124 (21): 1547.

https://doi.org/10.1182/blood.V124.21.1547.1547

Published: 2014

Journal Articles

Prevalence of Symptomatic Avascular Necrosis and the Operative Treatment in Adult Patients with Sickle Cell Disease

Morey A. Blinder, MD, Sarah Russel, Mikala Barnes, MA

Blood (2014) 124 (21): 1379.

https://doi.org/10.1182/blood.V124.21.1379.1379

Published: 2014

Journal Articles

Effect Of Antiplatelet Therapy On The Progression Of Osteonecrosis Of The Femoral Head: A Retrospective Analysis

Bertrand Routy, MD, Anthony Albers, MD, Alberto Carli, MD, Edward Harvey, MD, Chantal Séguin, MD

Blood (2013) 122 (21): 4811.

https://doi.org/10.1182/blood.V122.21.4811.4811

Published: 2013

Journal Articles

Increased Heparanase Level and Procoagulant Activity in Orthopedic Surgery Patients Receiving Prophylactic Dose of Enoxaparin,

Eli Peled, MD, Alexie Robitzki, MD, Elena Axelman, MSc., Doron Norman, MD, Benjamin Brenner, MD, Yona Nadir, M.D., Ph.D

Blood (2011) 118 (21): 3333.

https://doi.org/10.1182/blood.V118.21.3333.3333

Published: 2011

Journal Articles

A Phase II Study of Bortezomib (Velcade ® ), Cyclophosphamide (Cytoxan ® ), Thalidomide (Thalomid ® ) and Dexamethasone as First-Line Therapy for Multiple Myeloma

William Bensinger, Sundar Jagannath, MD, Robert Vescio, MD, Elber S. Camacho, MD, Jeffrey Lee Wolf, David H Irwin, MD, Gerardo Capo, III, MD, Marti McKinley, Phyllis Potts, David H. Vesole, MD, PhD, Amitabha Mazumder, MD, Dixie-Lee Esseltine, MD, Pamela Becker, John Crowley, PhD, Brian GM Durie, MD

Blood (2008) 112 (11): 94.

https://doi.org/10.1182/blood.V112.11.94.94

Published: 2008

Journal Articles

Is Differential Activity of Enoxaparin and Unfractionated Heparin According to the Location of Deep-Vein Thrombosis in Acute Ischemic Stroke Patients Driven by Different Pathogenic Mechanisms?.

Ludovic Drouet, David G. Sherman, Gregory W. Albers, Christopher Bladin, Cesare Fieschi, Alberto A. Gabbai, Carlos S. Kase, William O’Riordan, Graham F. Pineo

Blood (2007) 110 (11): 303.

https://doi.org/10.1182/blood.V110.11.303.303

Published: 2007

Journal Articles

Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.

Alexander G.G. Turpie, MD, Kenneth Alan Bauer, MD, Lars Borris, MD, Ola E. Dahl, MD, PhD, William D. Fisher, MD, Michael Gent, MD, PhD, Sylvia Haas, MD, Menno V. Huisman, MD, PhD, Ajay K. Kakkar, MD, PhD, Peter Kälebo, MD, PhD, Louis M. Kwong, MD, Martin Homering, PhD, Frank Misselwitz, MD, PhD, Bengt I. Eriksson, MD, PhD

Blood (2005) 106 (11): 277.

https://doi.org/10.1182/blood.V106.11.277.277

Published: 2005

Journal Articles

Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 2 Year Follow-Up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression.

Blood (2004) 104 (11): 1685.

https://doi.org/10.1182/blood.V104.11.1685.1685

Published: 2004

NARROW

Preoperative Anemia and Blood Transfusion Requirement during Hip Surgery: Synthetic and Real Patient Cohort Data

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B

Risk of Venous Thrombosis in Patients with Sickle Cell Trait after Orthopedic Surgery

Outcomes of Hip Arthroplasty in Sickle Cell Disease: A 20 Year Retrospective Review

Osteonecrosis of the Femoral Head in Sickle Cell Disease: Prevalence, Comorbidities and Surgical Outcomes in California

Multiple Myeloma Progression: Dependence on Bone Marrow Adipose Tissue

Total Hip Replacement in a Hemophilia-a Patient with High Titer Inhibitor

Treatment Outcomes in Pediatric Patients with Pulmonary Embolism Using Low Dose Tissue Plasminogen Activator Therapy

Prevalence of Symptomatic Avascular Necrosis and the Operative Treatment in Adult Patients with Sickle Cell Disease

Effect Of Antiplatelet Therapy On The Progression Of Osteonecrosis Of The Femoral Head: A Retrospective Analysis

Increased Heparanase Level and Procoagulant Activity in Orthopedic Surgery Patients Receiving Prophylactic Dose of Enoxaparin,

A Phase II Study of Bortezomib (Velcade ® ), Cyclophosphamide (Cytoxan ® ), Thalidomide (Thalomid ® ) and Dexamethasone as First-Line Therapy for Multiple Myeloma

Is Differential Activity of Enoxaparin and Unfractionated Heparin According to the Location of Deep-Vein Thrombosis in Acute Ischemic Stroke Patients Driven by Different Pathogenic Mechanisms?.

Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.

Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 2 Year Follow-Up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only